Transformation by murine and feline sarcoma viruses specifically blocks binding of epidermal growth factor to cells.
about
The Discovery and Early Days of TGF-β: A Historical PerspectiveEffects of in vivo-administered 2,3,7,8-tetrachlorodibenzo-p-dioxin on receptor binding of epidermal growth factor in the hepatic plasma membrane of rat, guinea pig, mouse, and hamsterRNA-tumour-virus genes and transforming genes: patterns of transmissionStructure and function of epigen, the last EGFR ligand.Abelson transformed fibroblasts lacking the EGF receptor are not tumourigenic in nude mice.Transformation-defective mutants of feline sarcoma virus which express a product of the viral src gene.From wavy hair to naked proteins: the role of transforming growth factor alpha in health and disease.Primary defect of insulin receptors in skin fibroblasts cultured from an infant with leprechaunism and insulin resistance.Modulation of the epidermal growth factor receptor by platelet-derived growth factor and choleragen: effects on mitogenesisTransferrin synthesis by inducer T lymphocytes.Head and neck cancer: gene therapy approaches. Part II: genes delivered.Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones.The human transforming growth factor type alpha coding sequence is not a direct-acting oncogene when overexpressed in NIH 3T3 cellsRoles for growth factors in cancer progression.Specific radiolabeling of a cell surface receptor for epidermal growth factor.Specific changes in the collagen phenotype of BALB 3T3 cells as a result of transformation by sarcoma viruses or a chemical carcinogenInvolvement of a high-molecular-weight polyprotein translational product of Snyder-Theilen Feline sarcoma virus in malignant transformation.Differences in mechanisms of transformation by independent feline sarcoma virus isolates.Constitutive activation of the interleukin 2 gene in the induction of spontaneous in vitro transformation and tumorigenicity of T cellsSpecificity of the inhibition of DNA synthesis by extracts from cloned normal, sarcoma-virus-transformed and revertant 3T3 cellsPhase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancerAn enhanced and sensitive autocrine stimulation by transforming growth factor-alpha is acquired in the brain metastatic variant of a human non-small-cell lung cancer cell lineControl of proliferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor, and thrombin.Distribution and modulation of the cellular receptor for transforming growth factor-betaProduction of platelet-derived growth factor-like molecules and reduced expression of platelet-derived growth factor receptors accompany transformation by a wide spectrum of agentsTransforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction.Genetics of cell surface receptors for bioactive polypeptides: binding of epidermal growth factor is associated with the presence of human chromosome 7 in human-mouse cell hybridsNucleotide sequence of immunoglobulin heavy chain joining segments between translocated VH and mu constant regions genesPrevalent deficiency in tumor cells of cycloheximide-induced cycle arrest.Genetic analysis of epidermal growth factor action: assignment of human epidermal growth factor receptor gene to chromosome 7Desensitization of enucleated cells to hormones and role of cytoskeleton in control of normal hormonal response.Increased secretion of type beta transforming growth factor accompanies viral transformation of cellsEpidermal growth factor receptor metabolism and protein kinase activity in human A431 cells infected with Snyder-Theilen feline sarcoma virus or harvey or Kirsten murine sarcoma virus.Energy requirement for degradation of tumor-associated protein p53Human squamous cell lung cancers express increased epidermal growth factor receptors.Epidermal growth factor receptor number decreases during rat liver regeneration.Decrease in epidermal growth factor receptor levels and production of material enhancing epidermal growth factor binding accompany the temperature-dependent changes from normal to transformed phenotype.Loss of epidermal growth factor requirement and malignant transformation.Antibodies to the epidermal growth factor receptor block the biological activities of sarcoma growth factor.Anti-sense transforming growth factor alpha oligonucleotides inhibit autocrine stimulated proliferation of a colon carcinoma cell line
P2860
Q28276556-9ED60D51-F251-4280-B763-9DB8954A53B9Q28646019-EE2F25F2-CC91-42DA-9526-65D0052F6305Q28756932-487C59B3-0CFA-48DE-ACD1-3D1F46CBB482Q33680363-7E95AE32-980E-4187-99C7-57E19161A5EDQ33880321-E4CEF21F-B86E-4F3C-950A-E4429C0B4E87Q33922047-ABF9F5EC-3ADD-40CF-B954-D8962474D18DQ33926726-38484AD6-73E4-4FB5-AC61-CAF85EF56ACFQ33982304-2F2B7F82-3810-463D-8EE0-27650E56596EQ34253812-E0C12908-F068-4E12-8387-D032FEF255EBQ34527249-F9EEDCA8-2267-47F6-9AB2-2372696032F5Q34560682-0F590EDF-2381-4815-AAC4-9184D699C943Q34610078-C70112D6-69BF-4E9D-8F1C-6E11A15D7D41Q34627570-E4D00A42-B1BB-4528-A3E2-7C5BE0B28C91Q34705858-E1E2CDDA-7A1A-4EA1-9461-0116693C0A82Q35035114-99702F9F-4E41-49DD-98E9-D8A4B59079FFQ35036930-B7898BCB-E214-453B-9C79-2EA7CCFA1EA2Q35235830-D20AF606-8F9D-4449-AEB7-BC4DF2D7FC46Q35238748-AC9D50D8-C396-4800-A8EC-E1F34E4E1733Q35653625-2EDEFD89-33DF-431E-A0CE-92F8ADD2DCB1Q36042752-B981F637-862B-4EF5-88C4-85CE9AAA2781Q36134525-1ED3ADE5-229B-4077-8170-6882FB9CEC60Q36141268-DA524EFB-7DEA-4C53-98D6-EC1676F8C541Q36199610-A11515A6-A99A-485C-B05C-042FFC079B03Q36217344-7C089D15-564B-4210-B414-EFE21214E6B9Q36257338-F341D84D-5B5D-47C3-83C9-AED0E3D00F79Q36394057-ACD6C56E-769E-410B-94B8-F956240F3374Q36394666-A3836F50-EC7F-4D9D-AD0E-6C871F773918Q36394813-79329F60-CB42-4EF7-BA10-A8A530794955Q36398077-EC177971-50E4-4C8D-9A40-94F31AAD091FQ36398632-D2162DC6-F297-4305-8607-F8D059EDA7A2Q36402799-B74E6D79-A7F5-4106-988B-18601E995F99Q36885110-BE4A8C36-025A-4AE2-8632-8A8B25FD87B4Q36910342-F2A467D1-BDF5-45EA-BA7F-7F569F9F1430Q36941962-7904C0DC-45B0-46D1-8902-96615211B6A4Q36993618-0049C1ED-E5B1-44B4-A219-5C31A363AD61Q36999532-37B9E759-5F9D-467F-8720-A8AF4CDE5EDCQ37336839-4BCA8328-95A3-432F-B611-350314B50E95Q37340106-8614FEFF-947D-4080-97D6-DF079739EFE7Q37349044-AEEA4F4B-736D-4540-B8B0-78EEF94A681EQ37374782-FC2399B3-300A-4F18-8941-A7E378B270AD
P2860
Transformation by murine and feline sarcoma viruses specifically blocks binding of epidermal growth factor to cells.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
1976年论文
@zh
1976年论文
@zh-cn
name
Transformation by murine and f ...... dermal growth factor to cells.
@en
type
label
Transformation by murine and f ...... dermal growth factor to cells.
@en
prefLabel
Transformation by murine and f ...... dermal growth factor to cells.
@en
P356
P1433
P1476
Transformation by murine and f ...... dermal growth factor to cells.
@en
P2093
De Larco JE
P2888
P356
10.1038/264026A0
P407
P577
1976-11-01T00:00:00Z
P6179
1008395587